Loading…

Sodium taurocholate co-transporting polypeptide deficiency

•What is already known on this subject? NTCP deficiency is associated with hypercholanemia.•What are the new findings? Serum bile acid levels may be related to the a mutation.•How might it impact on clinical practice in the foreseeable future? in failure to thrive, anicteric cholestasis, fetal demis...

Full description

Saved in:
Bibliographic Details
Published in:Clinics and research in hepatology and gastroenterology 2022-03, Vol.46 (3), p.101824-101824, Article 101824
Main Authors: Schneider, AL, Köhler, H., Röthlisberger, B., Grobholz, R., McLin, V.A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3234-27f3e49ce28e2009b70dc36742463d874a56ca79aca8a4cea1e527aba793dfdd3
cites cdi_FETCH-LOGICAL-c3234-27f3e49ce28e2009b70dc36742463d874a56ca79aca8a4cea1e527aba793dfdd3
container_end_page 101824
container_issue 3
container_start_page 101824
container_title Clinics and research in hepatology and gastroenterology
container_volume 46
creator Schneider, AL
Köhler, H.
Röthlisberger, B.
Grobholz, R.
McLin, V.A.
description •What is already known on this subject? NTCP deficiency is associated with hypercholanemia.•What are the new findings? Serum bile acid levels may be related to the a mutation.•How might it impact on clinical practice in the foreseeable future? in failure to thrive, anicteric cholestasis, fetal demise, or unexplained histological liver abnormalities associated with hypercholanemia. Introduction: Little is known about bile acid transporter defects on the basolateral side of hepatocytes. In 2015 Vaz et al. published a first case of SLC10A1 mutation causing Na-taurocholate Co-transporting Polypeptide deficiency with hypercholanemia and normal bilirubin and Autotaxin levels. The index patient presented with failure to thrive, but without pruritus or jaundice. Several new cases have been published since, but the full spectrum of clinical presentation of mutations in SLC10A is not known. The primary aim of this review is to report a patient with a novel homozygous mutation and discuss the findings in the light of all other reported cases to date. Material and methods: We describe the findings of a patient with a previously unreported homozygous mutation and review all published cases to date in English on PubMed. Results: Our female patient born in 2002 presented with a feeding disorder and failure to thrive akin to the first description by Vaz. Workup suggested underlying liver disease although she did not complain of pruritus. Serum levels of aminotransferases, alkaline phosphatase, gamma-glutamyl transferase and bilirubin were normal. Plasma bile acids were chronically elevated, up to 150-fold. A first liver biopsy performed at 2 years of age showed unspecific findings with focal steatosis. Ursodeoxycholic acid treatment was introduced and the liver panel monitored regularly. At age 14, a second biopsy was performed, and histology was within normal limits. At this time, serum Autotaxin levels were found to be in normal range. Finally, genetic analysis revealed a homozygous 5 bp deletion in the gene SLC10A1 resulting in a premature stop codon predicted to lead to a complete NTCP loss of function. Most other reported cases to date carry the c.800C>T (p.Ser267Phe) mutation and are asymptomatic. Discussion: NTCP deficiency appears to have a benign course as most patients are asymptomatic. Many patients seem to present with transient neonatal jaundice. Large variations in total plasma bile acid levels are observed between patients; they may be linked to the underly
doi_str_mv 10.1016/j.clinre.2021.101824
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2596012209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2210740121002023</els_id><sourcerecordid>2596012209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3234-27f3e49ce28e2009b70dc36742463d874a56ca79aca8a4cea1e527aba793dfdd3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbKn9ByI5ekndr2QTD4IUv6DgQQVvy3Z3oluSbNzdCP33pqb26FxmeHlnXuZB6JzgBcEkv9osdG1bDwuKKdlJBeVHaEopwang5P34MGMyQfMQNngonuFCkFM0YVxkgmRsiq5fnLF9k0TVe6c_Xa0iJNql0as2dM5H234knau3HXTRGkgMVFZbaPX2DJ1Uqg4w3_cZeru_e10-pqvnh6fl7SrVjDKeUlEx4KUGWgDFuFwLbDTLBac8Z6YQXGW5VqJUWhWKa1AEMirUepCYqYxhM3Q53u28--ohRNnYoKGuVQuuD5JmZY4JpbgcrHy0au9C8FDJzttG-a0kWO7AyY0cwckdODmCG9Yu9gn9ugFzWPrDNBhuRgMMf35b8DL8MgBjPegojbP_J_wAiMaAnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2596012209</pqid></control><display><type>article</type><title>Sodium taurocholate co-transporting polypeptide deficiency</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Schneider, AL ; Köhler, H. ; Röthlisberger, B. ; Grobholz, R. ; McLin, V.A.</creator><creatorcontrib>Schneider, AL ; Köhler, H. ; Röthlisberger, B. ; Grobholz, R. ; McLin, V.A.</creatorcontrib><description>•What is already known on this subject? NTCP deficiency is associated with hypercholanemia.•What are the new findings? Serum bile acid levels may be related to the a mutation.•How might it impact on clinical practice in the foreseeable future? in failure to thrive, anicteric cholestasis, fetal demise, or unexplained histological liver abnormalities associated with hypercholanemia. Introduction: Little is known about bile acid transporter defects on the basolateral side of hepatocytes. In 2015 Vaz et al. published a first case of SLC10A1 mutation causing Na-taurocholate Co-transporting Polypeptide deficiency with hypercholanemia and normal bilirubin and Autotaxin levels. The index patient presented with failure to thrive, but without pruritus or jaundice. Several new cases have been published since, but the full spectrum of clinical presentation of mutations in SLC10A is not known. The primary aim of this review is to report a patient with a novel homozygous mutation and discuss the findings in the light of all other reported cases to date. Material and methods: We describe the findings of a patient with a previously unreported homozygous mutation and review all published cases to date in English on PubMed. Results: Our female patient born in 2002 presented with a feeding disorder and failure to thrive akin to the first description by Vaz. Workup suggested underlying liver disease although she did not complain of pruritus. Serum levels of aminotransferases, alkaline phosphatase, gamma-glutamyl transferase and bilirubin were normal. Plasma bile acids were chronically elevated, up to 150-fold. A first liver biopsy performed at 2 years of age showed unspecific findings with focal steatosis. Ursodeoxycholic acid treatment was introduced and the liver panel monitored regularly. At age 14, a second biopsy was performed, and histology was within normal limits. At this time, serum Autotaxin levels were found to be in normal range. Finally, genetic analysis revealed a homozygous 5 bp deletion in the gene SLC10A1 resulting in a premature stop codon predicted to lead to a complete NTCP loss of function. Most other reported cases to date carry the c.800C&gt;T (p.Ser267Phe) mutation and are asymptomatic. Discussion: NTCP deficiency appears to have a benign course as most patients are asymptomatic. Many patients seem to present with transient neonatal jaundice. Large variations in total plasma bile acid levels are observed between patients; they may be linked to the underlying genetic mutation or to yet uncharacterized compensatory mechanisms. Longer follow-up is needed to evaluate the long-term consequences of this newly identified inherited disease of bile acid transport.</description><identifier>ISSN: 2210-7401</identifier><identifier>EISSN: 2210-741X</identifier><identifier>DOI: 10.1016/j.clinre.2021.101824</identifier><identifier>PMID: 34757153</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Adolescent ; Bile Acids and Salts ; Bilirubin ; Child, Preschool ; Failure to Thrive ; Female ; Humans ; Hypercholanemia ; Infant, Newborn ; NTCP deficiency ; Organic Anion Transporters, Sodium-Dependent ; Peptides ; Pruritus - etiology ; Symporters ; Taurocholic Acid</subject><ispartof>Clinics and research in hepatology and gastroenterology, 2022-03, Vol.46 (3), p.101824-101824, Article 101824</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3234-27f3e49ce28e2009b70dc36742463d874a56ca79aca8a4cea1e527aba793dfdd3</citedby><cites>FETCH-LOGICAL-c3234-27f3e49ce28e2009b70dc36742463d874a56ca79aca8a4cea1e527aba793dfdd3</cites><orcidid>0000-0002-1901-7967 ; 0000-0003-1514-8190</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34757153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneider, AL</creatorcontrib><creatorcontrib>Köhler, H.</creatorcontrib><creatorcontrib>Röthlisberger, B.</creatorcontrib><creatorcontrib>Grobholz, R.</creatorcontrib><creatorcontrib>McLin, V.A.</creatorcontrib><title>Sodium taurocholate co-transporting polypeptide deficiency</title><title>Clinics and research in hepatology and gastroenterology</title><addtitle>Clin Res Hepatol Gastroenterol</addtitle><description>•What is already known on this subject? NTCP deficiency is associated with hypercholanemia.•What are the new findings? Serum bile acid levels may be related to the a mutation.•How might it impact on clinical practice in the foreseeable future? in failure to thrive, anicteric cholestasis, fetal demise, or unexplained histological liver abnormalities associated with hypercholanemia. Introduction: Little is known about bile acid transporter defects on the basolateral side of hepatocytes. In 2015 Vaz et al. published a first case of SLC10A1 mutation causing Na-taurocholate Co-transporting Polypeptide deficiency with hypercholanemia and normal bilirubin and Autotaxin levels. The index patient presented with failure to thrive, but without pruritus or jaundice. Several new cases have been published since, but the full spectrum of clinical presentation of mutations in SLC10A is not known. The primary aim of this review is to report a patient with a novel homozygous mutation and discuss the findings in the light of all other reported cases to date. Material and methods: We describe the findings of a patient with a previously unreported homozygous mutation and review all published cases to date in English on PubMed. Results: Our female patient born in 2002 presented with a feeding disorder and failure to thrive akin to the first description by Vaz. Workup suggested underlying liver disease although she did not complain of pruritus. Serum levels of aminotransferases, alkaline phosphatase, gamma-glutamyl transferase and bilirubin were normal. Plasma bile acids were chronically elevated, up to 150-fold. A first liver biopsy performed at 2 years of age showed unspecific findings with focal steatosis. Ursodeoxycholic acid treatment was introduced and the liver panel monitored regularly. At age 14, a second biopsy was performed, and histology was within normal limits. At this time, serum Autotaxin levels were found to be in normal range. Finally, genetic analysis revealed a homozygous 5 bp deletion in the gene SLC10A1 resulting in a premature stop codon predicted to lead to a complete NTCP loss of function. Most other reported cases to date carry the c.800C&gt;T (p.Ser267Phe) mutation and are asymptomatic. Discussion: NTCP deficiency appears to have a benign course as most patients are asymptomatic. Many patients seem to present with transient neonatal jaundice. Large variations in total plasma bile acid levels are observed between patients; they may be linked to the underlying genetic mutation or to yet uncharacterized compensatory mechanisms. Longer follow-up is needed to evaluate the long-term consequences of this newly identified inherited disease of bile acid transport.</description><subject>Adolescent</subject><subject>Bile Acids and Salts</subject><subject>Bilirubin</subject><subject>Child, Preschool</subject><subject>Failure to Thrive</subject><subject>Female</subject><subject>Humans</subject><subject>Hypercholanemia</subject><subject>Infant, Newborn</subject><subject>NTCP deficiency</subject><subject>Organic Anion Transporters, Sodium-Dependent</subject><subject>Peptides</subject><subject>Pruritus - etiology</subject><subject>Symporters</subject><subject>Taurocholic Acid</subject><issn>2210-7401</issn><issn>2210-741X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1Lw0AQhhdRbKn9ByI5ekndr2QTD4IUv6DgQQVvy3Z3oluSbNzdCP33pqb26FxmeHlnXuZB6JzgBcEkv9osdG1bDwuKKdlJBeVHaEopwang5P34MGMyQfMQNngonuFCkFM0YVxkgmRsiq5fnLF9k0TVe6c_Xa0iJNql0as2dM5H234knau3HXTRGkgMVFZbaPX2DJ1Uqg4w3_cZeru_e10-pqvnh6fl7SrVjDKeUlEx4KUGWgDFuFwLbDTLBac8Z6YQXGW5VqJUWhWKa1AEMirUepCYqYxhM3Q53u28--ohRNnYoKGuVQuuD5JmZY4JpbgcrHy0au9C8FDJzttG-a0kWO7AyY0cwckdODmCG9Yu9gn9ugFzWPrDNBhuRgMMf35b8DL8MgBjPegojbP_J_wAiMaAnA</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Schneider, AL</creator><creator>Köhler, H.</creator><creator>Röthlisberger, B.</creator><creator>Grobholz, R.</creator><creator>McLin, V.A.</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1901-7967</orcidid><orcidid>https://orcid.org/0000-0003-1514-8190</orcidid></search><sort><creationdate>202203</creationdate><title>Sodium taurocholate co-transporting polypeptide deficiency</title><author>Schneider, AL ; Köhler, H. ; Röthlisberger, B. ; Grobholz, R. ; McLin, V.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3234-27f3e49ce28e2009b70dc36742463d874a56ca79aca8a4cea1e527aba793dfdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adolescent</topic><topic>Bile Acids and Salts</topic><topic>Bilirubin</topic><topic>Child, Preschool</topic><topic>Failure to Thrive</topic><topic>Female</topic><topic>Humans</topic><topic>Hypercholanemia</topic><topic>Infant, Newborn</topic><topic>NTCP deficiency</topic><topic>Organic Anion Transporters, Sodium-Dependent</topic><topic>Peptides</topic><topic>Pruritus - etiology</topic><topic>Symporters</topic><topic>Taurocholic Acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneider, AL</creatorcontrib><creatorcontrib>Köhler, H.</creatorcontrib><creatorcontrib>Röthlisberger, B.</creatorcontrib><creatorcontrib>Grobholz, R.</creatorcontrib><creatorcontrib>McLin, V.A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinics and research in hepatology and gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneider, AL</au><au>Köhler, H.</au><au>Röthlisberger, B.</au><au>Grobholz, R.</au><au>McLin, V.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sodium taurocholate co-transporting polypeptide deficiency</atitle><jtitle>Clinics and research in hepatology and gastroenterology</jtitle><addtitle>Clin Res Hepatol Gastroenterol</addtitle><date>2022-03</date><risdate>2022</risdate><volume>46</volume><issue>3</issue><spage>101824</spage><epage>101824</epage><pages>101824-101824</pages><artnum>101824</artnum><issn>2210-7401</issn><eissn>2210-741X</eissn><abstract>•What is already known on this subject? NTCP deficiency is associated with hypercholanemia.•What are the new findings? Serum bile acid levels may be related to the a mutation.•How might it impact on clinical practice in the foreseeable future? in failure to thrive, anicteric cholestasis, fetal demise, or unexplained histological liver abnormalities associated with hypercholanemia. Introduction: Little is known about bile acid transporter defects on the basolateral side of hepatocytes. In 2015 Vaz et al. published a first case of SLC10A1 mutation causing Na-taurocholate Co-transporting Polypeptide deficiency with hypercholanemia and normal bilirubin and Autotaxin levels. The index patient presented with failure to thrive, but without pruritus or jaundice. Several new cases have been published since, but the full spectrum of clinical presentation of mutations in SLC10A is not known. The primary aim of this review is to report a patient with a novel homozygous mutation and discuss the findings in the light of all other reported cases to date. Material and methods: We describe the findings of a patient with a previously unreported homozygous mutation and review all published cases to date in English on PubMed. Results: Our female patient born in 2002 presented with a feeding disorder and failure to thrive akin to the first description by Vaz. Workup suggested underlying liver disease although she did not complain of pruritus. Serum levels of aminotransferases, alkaline phosphatase, gamma-glutamyl transferase and bilirubin were normal. Plasma bile acids were chronically elevated, up to 150-fold. A first liver biopsy performed at 2 years of age showed unspecific findings with focal steatosis. Ursodeoxycholic acid treatment was introduced and the liver panel monitored regularly. At age 14, a second biopsy was performed, and histology was within normal limits. At this time, serum Autotaxin levels were found to be in normal range. Finally, genetic analysis revealed a homozygous 5 bp deletion in the gene SLC10A1 resulting in a premature stop codon predicted to lead to a complete NTCP loss of function. Most other reported cases to date carry the c.800C&gt;T (p.Ser267Phe) mutation and are asymptomatic. Discussion: NTCP deficiency appears to have a benign course as most patients are asymptomatic. Many patients seem to present with transient neonatal jaundice. Large variations in total plasma bile acid levels are observed between patients; they may be linked to the underlying genetic mutation or to yet uncharacterized compensatory mechanisms. Longer follow-up is needed to evaluate the long-term consequences of this newly identified inherited disease of bile acid transport.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>34757153</pmid><doi>10.1016/j.clinre.2021.101824</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-1901-7967</orcidid><orcidid>https://orcid.org/0000-0003-1514-8190</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2210-7401
ispartof Clinics and research in hepatology and gastroenterology, 2022-03, Vol.46 (3), p.101824-101824, Article 101824
issn 2210-7401
2210-741X
language eng
recordid cdi_proquest_miscellaneous_2596012209
source ScienceDirect Freedom Collection 2022-2024
subjects Adolescent
Bile Acids and Salts
Bilirubin
Child, Preschool
Failure to Thrive
Female
Humans
Hypercholanemia
Infant, Newborn
NTCP deficiency
Organic Anion Transporters, Sodium-Dependent
Peptides
Pruritus - etiology
Symporters
Taurocholic Acid
title Sodium taurocholate co-transporting polypeptide deficiency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A36%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sodium%20taurocholate%20co-transporting%20polypeptide%20deficiency&rft.jtitle=Clinics%20and%20research%20in%20hepatology%20and%20gastroenterology&rft.au=Schneider,%20AL&rft.date=2022-03&rft.volume=46&rft.issue=3&rft.spage=101824&rft.epage=101824&rft.pages=101824-101824&rft.artnum=101824&rft.issn=2210-7401&rft.eissn=2210-741X&rft_id=info:doi/10.1016/j.clinre.2021.101824&rft_dat=%3Cproquest_cross%3E2596012209%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3234-27f3e49ce28e2009b70dc36742463d874a56ca79aca8a4cea1e527aba793dfdd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2596012209&rft_id=info:pmid/34757153&rfr_iscdi=true